Yogarajah Joerg, Hutter Julie, Kahle Patrick, Beaujean Philipp, Tomic Marko, Hain Andreas, Sossalla Samuel, Neumann Thomas, Kuniss Malte
Department of Cardiology, Kerckhoff Heart Center, Campus Kerckhoff, Justus Liebig University Giessen, 61231, Bad Nauheim, Germany.
Department of Cardiology, Medical Clinic I, Justus Liebig University Giessen, 35392, Giessen, Germany.
J Interv Card Electrophysiol. 2025 May 29. doi: 10.1007/s10840-025-02078-9.
Single-shot ablation systems are widely used for pulmonary vein isolation (PVI) in atrial fibrillation (AF). The use of novel pulsed-field ablation (PFA) systems enables ablation beyond PVI, such as left atrial roof ablation (LARA), which may improve outcomes in persistent AF.
This study aimed to compare the acute efficacy, feasibility, and safety of PVI combined with LARA using three different single-shot ablation systems in patients with persistent AF and left atrial enlargement undergoing their first AF ablation.
Consecutive patients undergoing PVI with LARA using cryoballoon or PFA systems were included. Baseline characteristics, procedural parameters, and complication rates were assessed.
We included 125 patients with persistent AF and left atrial dilation, divided into cryoballoon (n = 65), pentaspline PFA (n = 30), and circular PFA (n = 30) groups. Acute PVI was achieved in 100% of veins. Fewer applications were required for LARA with cryoballoon vs. PFA (4 vs. 8 vs. 10, P < 0.001). Conduction block was confirmed in 95%, 100%, and 100% of patients (P = 0.421). Procedural times were longer with cryoballoon (87.0 vs. 64.0 vs. 68.0 min, P < 0.001), but fluoroscopy times were shorter (12.2 vs. 15.3 vs. 15.1 min, P = 0.002). Contrast medium use was higher in the cryoballoon group (P < 0.001). Adverse events were rare and predominantly minor, with three complications in the cryoballoon group and one in the PFA groups (P = 0.493).
All single-shot ablation systems demonstrated comparable efficacy and safety for PVI and LARA, with differences in procedural feasibility. Further and larger studies are needed.
单次消融系统广泛用于心房颤动(AF)的肺静脉隔离(PVI)。新型脉冲场消融(PFA)系统的应用能够进行PVI以外的消融,如左心房顶部消融(LARA),这可能改善持续性AF的治疗效果。
本研究旨在比较使用三种不同单次消融系统对首次接受AF消融的持续性AF和左心房扩大患者进行PVI联合LARA的急性疗效、可行性和安全性。
纳入连续使用冷冻球囊或PFA系统进行PVI联合LARA的患者。评估基线特征、手术参数和并发症发生率。
我们纳入了125例持续性AF和左心房扩张患者,分为冷冻球囊组(n = 65)、五棱形PFA组(n = 30)和圆形PFA组(n = 30)。100%的肺静脉实现了急性PVI。与PFA相比,冷冻球囊用于LARA的应用次数更少(分别为4次、8次和10次,P < 0.001)。95%、100%和100%的患者确认存在传导阻滞(P = 0.421)。冷冻球囊组的手术时间更长(分别为87.0分钟、64.0分钟和68.0分钟,P < 0.001),但透视时间更短(分别为12.2分钟、15.3分钟和15.1分钟,P = 0.002)。冷冻球囊组的造影剂使用量更高(P < 0.001)。不良事件罕见且主要为轻微事件,冷冻球囊组有3例并发症,PFA组有1例并发症(P = 0.493)。
所有单次消融系统在PVI和LARA方面均显示出相当的疗效和安全性,但手术可行性存在差异。需要进一步开展更大规模的研究。